Our Fight Against Cancer

Kintara Therapeutics is dedicated to the development of novel solid tumor cancer therapies for patients with unmet medical needs.

Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel cancer therapies.

Our Mission & Values

Guiding Principles for All of Our Actions

Our work is devoted to improving the life of patients and their families. Our values are the guiding principles that inform each decision and step we take.

Patients First

Our main focus is the patients and their families. We are dedicated to improving patient outcomes and their quality of life.


We research and develop cancer therapies that meet the highest standards of quality and scientific excellence. This is how we fight cancer. Excellence is committed from our team, and scientific and clinical collaborators.

Ethics and Transparency

We adhere to the highest standards of professionalism and ethics. We are transparent and inclusive in our communications with stakeholders.

Respect for People

Everyone at Kintara Therapeutics is working to build an environment of mutual honesty, respect, cooperation and inclusiveness.


We feel a sense of belonging to a world community. And locally, we are responsible and committed to the community where we live and work.

A Pipeline of Breakthrough Cancer Therapeutics

REM-001 is a second generation photosensitizer drug possessing multiple advantages over earlier generation PDT compounds.

REM-001’s indications include:

  • Cutaneous Metastatic Breast Cancer
  • Recurrent Basal Cell Carcinoma Nevus Syndrome
  • Hemodialysis Arteriovenous (AV) Access

View Our Pipeline

Current Clinical Trial

REM-001 Therapy for the treatment of serious cutaneous oncology indications.

This is an open-label, single cohort study to confirm dose, assessments and timing of response, to support future studies. The primary objective of the trial is to evaluate cutaneous tumor response within total target treatment field to REM-001 therapy assessed using standardized digital photography.

View Our Ongoing Clinical Trial

Our Platform Strategy:

Unleashing the Potential of Biology

Our platform strategy is built on a robust understanding of cancer biology. We use modern approaches in our laboratory studies to determine where we can solve problems in the treatment of drug and immune resistant cancer.

Our team has identified niches in the continuum of care where our therapeutic may address an unmet need. By showing that our treatments are active where others fail, we can implement clinical studies to demonstrate that our therapies may have the ability to improve patient outcomes.

Partnering with Respected Research Centers Around the Globe

Our collaborations with leading academic institutions play an important role in our approach to advancing research and development. Find out more about how we work with top institutions across the world.

University of Texas MD Anderson Cancer Center
University of California San Francisco
University of British Columbia
Luxembourg Institute of Health
B.C. Cancer Agency

Backed by Years of Experience

Our strong leadership team at Kintara Therapeutics possesses a wealth of expertise in the fields of drug discovery and development and translational cancer biology. The team brings a proven track record of successful product development and commercialization.

Join a Team That’s Making a Difference

Our mission is larger than a single drug or cancer indication. At Kintara Therapeutics, we are changing the game by advancing therapeutics that have demonstrated anti-cancer activity where other treatments may not be effective. Our people are the source of our success.

Join Our Team

Connect with Us

Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients who are failing or resistant to current treatment regimens.

If you'd like to learn more, we'd love to hear from you.

Get in Touch With Us